Unique cytologic features of thyroiditis caused by immune checkpoint inhibitor therapy for malignant melanoma by Trevor E. Angell, Le Min, Tad J. Wieczorek, F. Stephen Hodi

Get full text

Reduced Tumor Size of Untreated Papillary Thyroid Carcinoma After Immune Checkpoint Inhibitor–Induced Thyroiditis by Dennis H. Chen, MD, Heinz-Josef Lenz, MD, Melissa G. Lechner, MD/PhD, Trevor E. Angell, MD

Get full text

Evaluation of YouTube As A Source For Graves' Disease Information: Is High‐Quality Guideline‐Based Information Available? by Oluwatobiloba Ayo‐Ajibola, Ryan J. Davis, Claire Therriault, Christopher Lamb, Deborah Choe, Matthew E. Lin, Trevor E. Angell, Daniel I. Kwon

Get full text

Safety and efficacy of immune checkpoint inhibitor cancer therapy in patients with preexisting type 1 diabetes mellitus by Robin Hilder, Robin Hilder, Karen Tsai, Zoe Quandt, Dayna Isaacs, Alexandra Drakaki, Yan Xing, Gino K. In, Trevor E. Angell, Melissa G. Lechner

Get full text

Analytical and Clinical Validation of Expressed Variants and Fusions From the Whole Transcriptome of Thyroid FNA Samples by Trevor E. Angell, Lori J. Wirth, Maria E. Cabanillas, Maisie L. Shindo, Edmund S. Cibas, Joshua E. Babiarz, Yangyang Hao, Su Yeon Kim, P. Sean Walsh, Jing Huang, Richard T. Kloos, Giulia C. Kennedy, Steven G. Waguespack

Get full text

High-Dose Biotin Treatment for Secondary Progressive Multiple Sclerosis May Interfere with Thyroid Assays by Alissa Minkovsky, MD, PhD, Mark N. Lee, MD, PhD, Mitra Dowlatshahi, Trevor E. Angell, MD, Lilian S. Mahrokhian, MD, Athena K. Petrides, PhD, Stacy E.F. Melanson, MD, PhD, Ellen Marqusee, MD, Whitney W. Woodmansee, MD

Get full text